National Institute of Health-Grants

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

Published: 22 January 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute on Drug Abuse (NIDA)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

National Center for Complementary and Integrative Health (NCCIH)

Tribal Health Research Office (THRO)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

Office of Behavioral and

Click this link to continue reading the article on the source website.

Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025

Published: 22 January 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

This Notice provides information regarding the salary limitation for AHRQ grant and cooperative agreement awards and extramural research and development contract awards.

Since 1990, Congress has legislatively mandated a limitation on direct salary for individuals under AHRQ grant and cooperative agreement awards (referred to here as a grant) and contract awards. The mandate appears in the annual appropriation act that provides authority for AHRQ to incur obligations for a given Fiscal Year (FY). At this time, AHRQ has not received an FY 2025 appropriation and is operating under a Continuing Resolution, the “Continuing Appropriations and Extensions Act, 2025 (Public Law 118-83)”, that applies the terms and conditions of the Consolidated Appropriations Act, 2024.

The Consolidated Appropriations Act, 2024 restricts the amount of direct salary to Executive Level II of the Federal Executive pay scale. The Office of Personnel Management recently released new salary levels for the

Click this link to continue reading the article on the source website.

Notice of Informational Webinar for RFA-EY-25-002 Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 – Clinical Trial Optional)

Published: 22 January 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice of Informational Webinar for RFA-EY-25-002 Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 – Clinical Trial Optional)

This notice is to inform potential applicants for the “Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 – Clinical Trial Optional; RFA-EY-25-002)” funding opportunity that NEI and NIMHD will hold an informational webinar on February 7, 2025, at 2:30 PM Eastern Standard Time (US and Canada). The purpose of this RFA is to request applications that aim to implement and evaluate multi-level interventions and community engaged research to advance vision equity.  During the webinar, NEI and NIMHD staff will explain the goals and objectives of the notice of funding opportunity (NOFO) and answer questions from attendees.

All prospective applicants are invited to attend the webinar.  Participants are encouraged to submit their questions in advance

Click this link to continue reading the article on the source website.

Notice of Information: Reissuance of Notices of Funding Opportunity (NOFO) Global Brain and Nervous System Disorders Research Across the Lifespan (R01, R21)

Published: 22 January 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice of Information: Reissuance of Notices of Funding Opportunity (NOFO) “Global Brain and Nervous System Disorders Research Across the Lifespan” (R01, R21)

This notice is to inform the research community that the Fogarty International Center (FIC) intends to issue notices of funding opportunities (NOFOs) to solicit applications for its Global Brain and Nervous System Disorders Research Across the Lifespan (Global Brain) Program.

These NOFOs are intended to be reissuances of the now expired PAR-22-097 (R01 Clinical Trial Optional) and PAR-22-098 (R21 Clinical Trial Optional), along with companion funding opportunities that disallow clinical trials (R01 Clinical Trial Not Allowed and R21 Clinical Trial Not Allowed). All participating NIH institutes, centers, and offices will be clearly identified and designated on the published NOFOs. 

This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFOs are anticipated to be

Click this link to continue reading the article on the source website.